Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

Teva’s Potential $40 Billion Acquisition of Mylan Could Transform Generics Space

April 24, 2015 | by GlobalData | Comments

Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’s board of directors unanimously rejected the proposal, saying that the merger substantially undervalues the company and its future growth prospects.

TOPICS:

GW Pharmaceuticals Receives Orphan Drug Designation For Cannabidiol Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

April 24, 2015 11:15 am | by Globe Newswire | Comments

There are currently no FDA-approved medicines specifically indicated for NHIE.

TOPICS:

Pipeline Advancements And Asset Acquisitions Fueled Mid-Cap Biotech R&D in 2014

April 24, 2015 11:09 am | by Global Data | Comments

The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says research and consulting firm GlobalData.

TOPICS:

Hospira Recalls One Lot Of Bupivacaine HCl Injection

April 24, 2015 11:02 am | by U.S. Food And Drug Administration | Comments

Hospira is issuing a voluntary recall of one lot of Preservative-Free Bupivacaine HCl Injection, USP, 0.5% (5 mg/mL), 30 mL Single-dose (NDC: 0409-1162-02, Lot 38-515-DK, Expiry 1FEB2016) due to one confirmed customer complaint of orange and black, visible particles embedded and free floating within a single-dose glass teartop vial.

TOPICS:
Advertisement

Malaria Vaccine is a Letdown But Could Still Reduce Cases

April 24, 2015 10:30 am | by MARIA CHENG, AP Medical Writer | Comments

The world's leading malaria vaccine candidate appears to be a disappointment, with final study results showing it doesn't work very well and that initial protection fades over time.

TOPICS:

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 4:48 pm | by The Associated Press | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies.

TOPICS:

Catalent Awarded Grant as Part of a Vaccine Research Consortium

April 23, 2015 10:45 am | by Catalent | Comments

Catalent announced that it has received a significant project grant as part of a consortium looking to evaluate, develop and manufacture thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.

TOPICS:

Mylan Launches Generic Sofosbuvir Tablets, MyHep, in India

April 23, 2015 10:30 am | by PRNewswire | Comments

The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.

TOPICS:

Oral Therapies The Next Step For Rheumatoid Arthritis

April 23, 2015 10:22 am | by Frost & Sullivan | Comments

The market for other rheumatoid arthritis therapeutics is considerable as many patients do not respond well to TNF inhibitors.

TOPICS:
Advertisement

McCormack Pharma's Discovery Could Mean New Guidelines For Anti-Platelet Drug Use

April 23, 2015 10:16 am | by PRNewswire | Comments

Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial infarction, stent thrombosis, and stroke because of insufficient clopidogrel-induced platelet inhibition.

TOPICS:

Study: Drug Successfully Treats Ebola Strain

April 23, 2015 10:07 am | by Andy Szal, Digital Reporter | Comments

Researchers then gave the TKM-Ebola-Makona drug to three of the monkeys, each of whom developed milder symptoms and fully recovered from the disease.

TOPICS:

Pfizer Says Leukemia Drug Met 1 Goal in Study

April 22, 2015 5:03 pm | by The Associated Press | Comments

Pfizer said that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.

TOPICS:

With Bird Flu Spreading, USDA Starts on Potential Vaccine

April 22, 2015 5:00 pm | by STEVE KARNOWSKI, Associated Press | Comments

The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.

TOPICS:

INTERPHEX Pic of The Day

April 22, 2015 11:44 am | by Advantage Business Media | Comments

FETTE Compacting's Patrice Gesner poses with their Editor's Choice INTERPHEX Exhibitor Award.

TOPICS:

Capricor Granted FDA Orphan Drug Designation For Allogeneic Cardiosphere-Derived Cells

April 22, 2015 11:28 am | Comments

Capricor Therapeutics, Inc. today announced that it has been granted orphan drug designation by FDA for its cell therapeutic product candidate, CAP-1002, for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD).

TOPICS:

Astellas And Potenza Partner to Create Immuno-Oncology Therapeutics

April 22, 2015 11:25 am | by PRNewswire | Comments

Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration. 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading